Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila A Doggrell

Showing results (121-130 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|May 28, 2004
Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary arterySheila A Doggrell
Expert Opinion on Therapeutic Targets|October 8, 2004
Inhibition of cardiac cytochrome P450: a new approach to cardiac ischaemia and reperfusion damageSheila A Doggrell
Expert Opinion on Pharmacotherapy|October 27, 2004
Telmisartan - killing two birds with one stoneSheila A Doggrell
Drug News & Perspectives|January 5, 2006
Inflammation, the key to much pathologySheila A Doggrell
Expert Opinion on Pharmacotherapy|February 28, 2002
Clopidogrel: a CURE in acute coronary syndromes?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|January 19, 2008
Celecoxib to prevent restenosis--results from the COREA-TAXUS trialSheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|March 25, 2006
Bradykinin B2 receptors as a target in diabetic nephropathySheila A Doggrell
Expert Opinion on Investigational Drugs|January 26, 2025
Are glucagon-like peptide-1 (GLP-1) receptor agonists useful in treating Parkinson's disease (PD)? Does the clinical trial with lixisenatide add anything?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|February 10, 2025
Will elinzanetant, a neurokinin receptor antagonist, have a role in the treatment of hot flashes?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|July 29, 2006
Natalizumab in multiple sclerosis: proceed with caution?Sheila A Doggrell
Pageof 22

Showing results (121-130 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|May 28, 2004
Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary arterySheila A Doggrell
Expert Opinion on Therapeutic Targets|October 8, 2004
Inhibition of cardiac cytochrome P450: a new approach to cardiac ischaemia and reperfusion damageSheila A Doggrell
Expert Opinion on Pharmacotherapy|October 27, 2004
Telmisartan - killing two birds with one stoneSheila A Doggrell
Drug News & Perspectives|January 5, 2006
Inflammation, the key to much pathologySheila A Doggrell
Expert Opinion on Pharmacotherapy|February 28, 2002
Clopidogrel: a CURE in acute coronary syndromes?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|January 19, 2008
Celecoxib to prevent restenosis--results from the COREA-TAXUS trialSheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|March 25, 2006
Bradykinin B2 receptors as a target in diabetic nephropathySheila A Doggrell
Expert Opinion on Investigational Drugs|January 26, 2025
Are glucagon-like peptide-1 (GLP-1) receptor agonists useful in treating Parkinson's disease (PD)? Does the clinical trial with lixisenatide add anything?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|February 10, 2025
Will elinzanetant, a neurokinin receptor antagonist, have a role in the treatment of hot flashes?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|July 29, 2006
Natalizumab in multiple sclerosis: proceed with caution?Sheila A Doggrell
Pageof 22